The Clorox Company
CLX
$118.69
-$0.70-0.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.16% | -2.64% | -1.98% | 6.17% | -4.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.16% | -2.64% | -1.98% | 6.17% | -4.01% |
| Cost of Revenue | -3.28% | -7.42% | -6.05% | -1.69% | -10.17% |
| Gross Profit | 4.67% | 3.91% | 3.61% | 17.89% | 5.51% |
| SG&A Expenses | -4.48% | 0.25% | 1.16% | 5.50% | 3.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -121.88% | -102.50% | -85.71% | -60.71% | 0.00% |
| Total Operating Expenses | -4.29% | -5.63% | -4.33% | 0.16% | -6.16% |
| Operating Income | 29.93% | 18.37% | 14.41% | 58.08% | 13.41% |
| Income Before Tax | 170.85% | 161.94% | 312.10% | 261.59% | 67.23% |
| Income Tax Expenses | 139.62% | 116.67% | 179.69% | 238.46% | 37.66% |
| Earnings from Continuing Operations | 182.19% | 181.35% | 403.23% | 273.74% | 81.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.67% | -25.00% | 15.38% | 0.00% | 0.00% |
| Net Income | 189.29% | 189.17% | 471.25% | 315.12% | 87.92% |
| EBIT | 29.93% | 18.37% | 14.41% | 58.08% | 13.41% |
| EBITDA | 22.93% | 13.14% | 10.12% | 42.77% | 10.39% |
| EPS Basic | 191.19% | 189.29% | 474.73% | 314.50% | 86.94% |
| Normalized Basic EPS | 35.48% | 21.98% | 19.07% | 66.05% | 13.96% |
| EPS Diluted | 191.94% | 189.63% | 487.33% | 325.33% | 88.86% |
| Normalized Diluted EPS | 35.15% | 21.63% | 18.86% | 65.91% | 13.98% |
| Average Basic Shares Outstanding | -0.52% | -0.20% | 0.10% | 0.31% | 0.47% |
| Average Diluted Shares Outstanding | -0.29% | 0.06% | 0.22% | 0.34% | 0.48% |
| Dividend Per Share | 1.66% | 1.67% | 1.67% | 1.68% | 1.69% |
| Payout Ratio | -0.65% | -0.65% | -0.82% | -0.76% | -0.46% |